PureKana by PHM Brands, LLC / Viobin, LLC

PureKana by

Drug Labeling and Warnings

PureKana by is a Otc medication manufactured, distributed, or labeled by PHM Brands, LLC, Viobin, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

PUREKANA- pain relief ointment lotion 
PHM Brands, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active Ingredient(s)

Menthol 4% v/v. Purpose:Topical Analgesic; Capsaicin 0.025% Purpose: Topical Analgesic

Purpose

Topical Analgesic

Use

For the temporary relief of minor aches and pains of sore muscles and joints associated with smple backache, arthritis, strains, bruises, and sprains.

Warnings

For External Use Only

Do not use: on wounds or damaged skin, if seal is missing or broken

Do not apply to irritated skin or if excessive irritation develops, avoid contact with eyes or mucous membranes, if condition worsens, or if symptoms persist more than 7 days or clear up and reoccur within a few days, discontinue the use of this product and consult a health care provider, do not bandage tightly

Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and recur.

Keep out of reach of children. If swallowed, get medical help or contact Poison Control right away.

If pregnant or breast-feeding, ask a health care provider before use

Directions

Adults: Apply to affected area no more than 3 to 4 times daily

Children: Consult a health care provider before use

Other Information

Store at 20-25C (68-77F)

Inactive Ingredients

Water, Organic Coconut Oil, Stearic Acid, Shea Butter, Emulsifying Wax (Cetyl Alcohol, Stearyl Alcohol, Polysorbate 60), Mehtylsulfonylmethane (MSM), Broad Spectrum Hemp Extract (CBD, CBG, CBN, CBDV*) (Aerial Parts), Phenoxyethanol, Xanthan Gum, Tetrasodium Glutamate Diacetate

* CBD (Cannabidiol), CBG (Cannabigerol), CBN (Cannabinol), CBDV (Cannabidivarin)

Lotion Label

PUREKANA 
pain relief ointment lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 78759-004
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL, UNSPECIFIED FORM3.88 g  in 100 mL
CAPSAICIN (UNII: S07O44R1ZM) (CAPSAICIN - UNII:S07O44R1ZM) CAPSAICIN0.026 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
STEARIC ACID (UNII: 4ELV7Z65AP) 7.33 g  in 100 mL
COCONUT OIL (UNII: Q9L0O73W7L) 15.74 g  in 100 mL
STEARYL ALCOHOL (UNII: 2KR89I4H1Y) 1.57 g  in 100 mL
SHEA BUTTER (UNII: K49155WL9Y) 5.75 g  in 100 mL
CETYL ALCOHOL (UNII: 936JST6JCN) 2.44 g  in 100 mL
POLYSORBATE 60 (UNII: CAL22UVI4M) 1.57 g  in 100 mL
CANNABIDIOL (UNII: 19GBJ60SN5) 0.82 g  in 100 mL
PHENOXYETHANOL (UNII: HIE492ZZ3T) 0.59 g  in 100 mL
XANTHAN GUM (UNII: TTV12P4NEE) 0.16 g  in 100 mL
TETRASODIUM GLUTAMATE DIACETATE (UNII: 5EHL50I4MY) 0.16 g  in 100 mL
DIMETHYL SULFONE (UNII: 9H4PO4Z4FT) 0.96 g  in 100 mL
WATER (UNII: 059QF0KO0R) 54.84 g  in 100 mL
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 78759-004-03100 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/18/202112/31/2021
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34805/18/202112/31/2021
Labeler - PHM Brands, LLC (081176131)
Registrant - Viobin, LLC (805279234)
Establishment
NameAddressID/FEIBusiness Operations
Viobin, LLC805279234manufacture(78759-004) , pack(78759-004)

Revised: 1/2022
 

Trademark Results [PureKana]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PUREKANA
PUREKANA
97271188 not registered Live/Pending
PureKana LLC
2022-02-17
PUREKANA
PUREKANA
88129568 not registered Live/Pending
OMNI Commerce Corp.
2018-09-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.